Camilla Sylvest
- Role
-
Board member
Elected to the Board in 2026 and regarded as an independent board member.
- Member of the Audit Committee
Special competencies
Nearly 30 years of experience in global business leadership, including heading up operational responsibility for Novo Nordisk affiliates in Denmark, Norway, Germany, South East Asia, and Region China. Most recently served as Executive Vice President for Global Commercial Strategy, Corporate Communication and Sustainability at Novo Nordisk A/S, with responsibility for global commercial strategy, marketing, and major product launches, including in the areas of chronic weight management and diabetes.
Current positions
Member of the Board of Directors of argenx SE and Getinge AB.
